ArticleJCEM case reports2026
Recurrent Orbital Metastases in Follicular Variant Papillary Thyroid Carcinoma After Recombinant Human Thyrotropin.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recombinant human thyrotropin (rhTSH) is generally well tolerated with minimal adverse effects. Symptomatic tumor expansion following rhTSH has been previously reported in the literature. Generally, these cases have involved known metastasis of aggressive variants. In this report we present a case of follicular variant papillary thyroid carcinoma (FVPTC) with recurrent treated orbital metastases and adverse response to rhTSH. Following a second dose of rhTSH, the patient reported right eye proptosis, and edema was noted on imaging. Iodine-131 scan demonstrated intense right orbital uptake with intracranial extension verified on head scans. Biopsy confirmed FVPTC and she underwent orbitotomy and enucleation. Our case illustrates the potential risk of symptomatic expansion even in cases of previously treated metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.